a friendly research digest ~ the alpha-MSH tripeptide
KPV peptide is the alpha-MSH tripeptide studied for anti-inflammatory and wound-healing effects.
Three amino acids, lysine-proline-valine, snipped from the tail of a larger hormone. We walk through what the cell and animal studies actually measured, gently and with every figure cited.
The short version
Here is KPV peptide in plain words. KPV is a tiny molecule made of three amino acids — lysine, proline, and valine — that comes from the tail end of a natural body hormone called alpha-MSH. In lab dishes and in mice, it calms inflammation: it quiets the cell's main "turn on the alarm" switches and lowers the inflammatory signals cells release. The biggest body of work is in the gut, with smaller sets of studies on skin and eye wound healing. One honest catch sits up front, in a friendly note: there are no published human trials of KPV, so everything here is mechanistic and animal-model work, not proof in people.
What Is KPV Peptide?
KPV peptide is a linear tripeptide, lysine-proline-valine (Lys-Pro-Val), that corresponds to the last three residues — positions 11 to 13 — of alpha-melanocyte-stimulating hormone (alpha-MSH, a small natural signaling molecule, or neuropeptide, the body makes) [4]. Its molecular formula is C16H30N4O4 and its molecular weight is about 342 Da [4]. KPV is not an independently circulating hormone; it is the C-terminal fragment of a larger one [4].
The reason researchers care about this exact three-residue piece is a clean separation of jobs. Alpha-MSH has two famous activities: it calms inflammation, and it darkens skin (the pigmentary, or melanogenic, action). KPV keeps the anti-inflammatory half and drops the pigment half [4]. A landmark review describes KPV as the C-terminal tripeptide of alpha-MSH that "retains broad anti-inflammatory activity while lacking the pigmentary action of the full hormone" [4]. That makes KPV a useful research handle for the calming effect, with no tanning effect attached.
If you have read about how KPV reduces inflammation or about PepT1 and gut uptake, this site collects those findings into one cited reading shelf. The companion pages cover KPV wound healing research and KPV legal status in depth.
KPV Peptide Benefits Documented in Research
<a id="benefits"></a>Across preclinical models, KPV peptide benefits cluster into three areas, all measured in cells or animals rather than people. First, anti-inflammatory signaling: nanomolar KPV reduced activation of NF-kB (a master switch, or transcription factor, that turns on many inflammation genes) and of MAP-kinase pathways (the relay enzymes that pass inflammatory and stress messages along), and it lowered pro-inflammatory cytokine release in human intestinal-epithelial and immune cells [1].
Second, the gut. Oral KPV reduced the severity of chemically induced colitis (inflammation of the colon) in mice in two separate models [1]. In a related study, KPV-treated mice recovered earlier and regained body weight more strongly, with less inflammatory infiltrate and lower myeloperoxidase activity — an enzyme used as a tissue marker of neutrophil inflammation [2].
Third, wound repair. Topical KPV fully re-epithelialized rabbit cornea — 8 of 8 treated corneas versus 0 of 8 placebo by 60 hours — through a nitric-oxide-dependent mechanism [6], and 2019 and 2025 reviews evaluate melanocortin tripeptides including KPV for cutaneous wound healing and skin regeneration [7]. These are detailed on the KPV wound healing research page. No approved human indications exist for any of these uses.
Why a "Store" That Sells Nothing
KPV Store is a reading shelf, not a checkout. The name points at a little library of the KPV peptide literature — a place to browse what the studies found — not a place to buy anything. We do not manufacture, sell, or supply KPV, and we name no vendor, pharmacy, or clinic.
The honest framing matters here because the marketing around this peptide tends to outrun the evidence. KPV has a coherent, genuinely interesting anti-inflammatory profile in the lab, but the entire efficacy record is in vitro and animal [1][2]. We try to say plainly what each study measured, mark what is confirmed, and flag what is still missing — most of all, human data. For the regulatory picture, see KPV legal status; for everything else, the frequently asked questions page is the quick index.